Literature DB >> 33893080

Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells.

Olga Lilia Garibay-Cerdenares1,2, Luz Victoria Sánchez-Meza1, Sergio Encarnación-Guevara3, Magdalena Hernández-Ortíz3, Gabriel Martínez-Batallar3, Francisco Israel Torres-Rojas1, Miguel Ángel Mendoza-Catalán1, Oscar Del Moral-Hernández1, Marco Antonio Leyva-Vázquez1, Berenice Illades-Aguiar4.   

Abstract

BACKGROUND/AIM: The E6 genotypic variants of HPV 16 identified in lesions of women with cervical cancer (CC) in Southern of Mexico include the E-G350, AAa, AAc, E-C188/G350, and E-A176/G350, transcriptomic analysis cells transfected with those variants showed to induce differential expression of the host genes involved in the development of CC, the aim of this work was to understand how the over-expression of the E6 oncoprotein and its variants can induce molecular mechanisms that lead to more aggressive HPV 16 phenotypes in cervical cancer and which proteins could be associated with the process.
MATERIALS AND METHODS: Total extracts from C33A, C33A mock, C33A AAa, C33A E-C188/G350, C33A E-A176/G350, and C33A E-prototype cells were analyzed using 2D electrophoresis, PDQuest software and mass spectrometry, validation of results was performed through qPCR.
RESULTS: Statistically significant differential expression of 122 spots was detected, 12 of the identified proteins were associated with metabolism and metabolic programming. Out of these CCT8, ENO and ALDH1A were further validated.
CONCLUSION: CCT8 and ALDH1A were found to be over-expressed in C33A AAa and C33A E-A176/G350, compared to the E prototype. Both proteins could be associated with a most aggressive phenotype due to their relationship with metabolism, protein folding and stemness, mechanisms associated to E6 that could be useful in the design of new therapies. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  2D electrophoresis; HPV 16 E6 variants; cervical cancer; proteomic analysis

Mesh:

Substances:

Year:  2021        PMID: 33893080      PMCID: PMC8126335          DOI: 10.21873/cgp.20258

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  70 in total

1.  Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.

Authors:  M L Tornesello; S Losito; G Benincasa; F Fulciniti; G Botti; S Greggi; L Buonaguro; F M Buonaguro
Journal:  Gynecol Oncol       Date:  2011-01-06       Impact factor: 5.482

2.  The t-complex polypeptide 1 complex is a chaperonin for tubulin and actin in vivo.

Authors:  H Sternlicht; G W Farr; M L Sternlicht; J K Driscoll; K Willison; M B Yaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 3.  The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.

Authors:  Radosław Januchowski; Karolina Wojtowicz; Maciej Zabel
Journal:  Biomed Pharmacother       Date:  2013-05-09       Impact factor: 6.529

4.  Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium.

Authors:  Minh M Nguyen; Marie L Nguyen; Georgina Caruana; Alan Bernstein; Paul F Lambert; Anne E Griep
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 5.  Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Authors:  Surendra Singh; Chad Brocker; Vindhya Koppaka; Ying Chen; Brian C Jackson; Akiko Matsumoto; David C Thompson; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-11-27       Impact factor: 7.376

6.  Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern Mexico.

Authors:  Julio Ortiz-Ortiz; Luz del Carmen Alarcón-Romero; Marco Antonio Jiménez-López; Víctor Hugo Garzón-Barrientos; Itzel Calleja-Macías; Hugo Alberto Barrera-Saldaña; Marco Antonio Leyva-Vázquez; Berenice Illades-Aguiar
Journal:  Virol J       Date:  2015-02-22       Impact factor: 4.099

Review 7.  Human papillomavirus molecular biology and disease association.

Authors:  John Doorbar; Nagayasu Egawa; Heather Griffin; Christian Kranjec; Isao Murakami
Journal:  Rev Med Virol       Date:  2015-03       Impact factor: 6.989

8.  Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer.

Authors:  Alfredo Toledo-Leyva; Julio César Villegas-Pineda; Sergio Encarnación-Guevara; Dolores Gallardo-Rincón; Patricia Talamás-Rohana
Journal:  Proteome Sci       Date:  2018-02-13       Impact factor: 2.480

9.  Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients.

Authors:  Eliza Kwiatkowska-Borowczyk; Patrycja Czerwińska; Jacek Mackiewicz; Katarzyna Gryska; Urszula Kazimierczak; Katarzyna Tomela; Anna Przybyła; Anna Karolina Kozłowska; Łukasz Galus; Łukasz Kwinta; Ewelina Dondajewska; Agnieszka Gąbka-Buszek; Monika Żakowska; Andrzej Mackiewicz
Journal:  Oncoimmunology       Date:  2018-08-24       Impact factor: 8.110

10.  Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis.

Authors:  Anne E Showalter; Ana C Martini; Daniel Nierenberg; Kristen Hosang; Naima Ahmed Fahmi; Priya Gopalan; Amr S Khaled; Wei Zhang; Annette R Khaled
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more
  2 in total

Review 1.  Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.

Authors:  J Omar Muñoz-Bello; Adela Carrillo-García; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

2.  Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.

Authors:  Kerry Dust; Michael Carpenter; Julie Chih-Yu Chen; Chris Grant; Stuart McCorrister; Garret R Westmacott; Alberto Severini
Journal:  Viruses       Date:  2022-08-12       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.